![Recent advances in targeted therapies in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text Recent advances in targeted therapies in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-023-01424-6/MediaObjects/13045_2023_1424_Fig3_HTML.png)
Recent advances in targeted therapies in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
![Early response evaluation by single cell signaling profiling in acute myeloid leukemia | Nature Communications Early response evaluation by single cell signaling profiling in acute myeloid leukemia | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-35624-4/MediaObjects/41467_2022_35624_Fig1_HTML.png)
Early response evaluation by single cell signaling profiling in acute myeloid leukemia | Nature Communications
![Current Oncology | Free Full-Text | Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology Current Oncology | Free Full-Text | Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology](https://www.mdpi.com/curroncol/curroncol-29-00491/article_deploy/html/images/curroncol-29-00491-g001.png)
Current Oncology | Free Full-Text | Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
Improving Survival in Acute Myeloid Leukemia: Pick the Best Subjects? | Journal of Clinical Oncology
![PDF) Acute Myeloid Leukemia: A focus on Risk Factors, Clinical Presentation, Diagnosis and Possible Lines of Management PDF) Acute Myeloid Leukemia: A focus on Risk Factors, Clinical Presentation, Diagnosis and Possible Lines of Management](https://i1.rgstatic.net/publication/317741600_Acute_Myeloid_Leukemia_A_focus_on_Risk_Factors_Clinical_Presentation_Diagnosis_and_Possible_Lines_of_Management/links/60051e2292851c13fe1be492/largepreview.png)
PDF) Acute Myeloid Leukemia: A focus on Risk Factors, Clinical Presentation, Diagnosis and Possible Lines of Management
![Acute Myeloid Leukemia with 8:21 Translocation and Aberrant B-Marker Expression | Biomedical Research and Therapy Acute Myeloid Leukemia with 8:21 Translocation and Aberrant B-Marker Expression | Biomedical Research and Therapy](http://bmrat.org/public/journals/2/article_822_cover_en_US.png)
Acute Myeloid Leukemia with 8:21 Translocation and Aberrant B-Marker Expression | Biomedical Research and Therapy
Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML | PLOS ONE
![PDF) Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia PDF) Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia](https://i1.rgstatic.net/publication/349071749_Unsupervised_Flow_Cytometry_Analysis_Allows_for_an_Accurate_Identification_of_Minimal_Residual_Disease_Assessment_in_Acute_Myeloid_Leukemia/links/603fbed64585154e8c74f844/largepreview.png)